Nanomaterials as potential transporters of HDAC inhibitors
Nanomedicine that combines technology with medical diagnostics and therapeutics is now advancing to greater heights for its significant potential in drug delivery. Epigenetic modifications that alter gene expressions patterns are often associated with disease progression and therapeutic resistance....
Main Authors: | Cristabelle De Souza, Zhao Ma, Aaron Raymond Lindstrom, Biswa Prasun Chatterji |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Medicine in Drug Discovery |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590098620300270 |
Similar Items
-
HDAC inhibitor attenuates rat traumatic brain injury induced neurological impairments
by: Yiming Lu, et al.
Published: (2023-08-01) -
Nghiên cứu tương tác của vorinostat với enzyme HDAC8 (1T67) bằng Autodock
by: Nguyễn Cường Quốc, et al.
Published: (2020-12-01) -
Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues
by: Bartosz Bieszczad, et al.
Published: (2021-08-01) -
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma
by: Wenjie Gong, et al.
Published: (2022-02-01) -
Vorinostat decrease M2 macrophage polarization through ARID1A6488delG/HDAC6/IL-10 signaling pathway in endometriosis-associated ovarian carcinoma
by: Tsung-Hua Hsieh, et al.
Published: (2023-05-01)